SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is trending with strong community engagement, highlighted by its multi-chain presence across Solana, Cronos, Ethereum, and BNB. Enthusiasts are actively discussing its unique permissionless bridge-burn mechanism, which promotes a deflationary supply, and view it as a 'real deal' meme coin with significant organic growth and development.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network (BNAI) is experiencing explosive momentum, driven by a powerful short squeeze that followed a recent $2 million deal announcement. The trading community is comparing its parabolic price action to historic squeezes, citing low float and high borrow rates as key factors, though some caution about the extreme run-up and potential for a sharp reversal.

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc - ADR

AstraZeneca PLC

AstraZeneca is trending due to a flurry of positive clinical trial data and recent regulatory approvals across its oncology portfolio, including significant advancements for Enhertu in breast cancer and Tagrisso in lung cancer. Community discussion is actively centered on the company's strategic commitment to expand its U.S. manufacturing with a substantial investment, particularly in light of drug pricing negotiations and a potential tariff exemption deal with the Trump administration. Investors are also noting AZN's planned full NYSE listing, viewing it as a robust and diversifying pharmaceutical leader.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana (CVNA) is a focal point of intense market debate, propelled by recent analyst upgrades to significantly higher price targets and ongoing discussions around a class action lawsuit related to alleged stock manipulation. Community discussion is sharply split, with many labeling the company a "scam" or "fraudulent" due to its high valuation and subprime auto loan exposure, while bullish traders highlight its resilience, "short squeeze" dynamics, and ability to defy fundamental skepticism. This ongoing controversy underscores broader market concerns about speculative valuations and institutional influence on price action.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo (BTGO) is trending due to a significant post-IPO decline, with shares falling sharply after initially opening above the offer price. This sharp drop is fueling intense community debate, as many draw comparisons to other volatile crypto-related IPOs, while others highlight the company's institutional digital asset custody business, reported profitability, and federal bank charter as reasons for a potential rebound.

What is the project about? Vara Network is a substrate-based future proof smart contract platform that is fast, scalable, and makes it simple to create and deploy next-generation Web3.0 dApps Vara is the first standalone network in the Gear Protocol  Gear is a next-gen cloud infrastructure platform providing most intuitive and frictionless environment for web2 and web3 developers to build complex infrastructure solutions and disruptive dApps for any ecosystem  What makes your project unique? Vara is built upon three core concepts: The actor model, and persistent memory — two widely adopted primitives from massive computation and microservices architecture spaces  Wasm — a WebAssembly-based virtual machine that runs on all modern browsers. Proven to be faster than any alternative web2 virtual machines  Vara was created to serve as a wasm-native hub for innovative protocols that leverage parallel execution and asynchronous programming to deliver leading decentralized products in any segment  History of your project. Gear Protocol and the Vara Network were originally created by Nikolay Volf, one of the core developers of Polkadot. In 2021, he embarked on building an advanced layer 1 smart contract platform using Substrate, Polkadot's custom framework. His vision included creating a platform that enables fast and efficient execution of robust, feature-rich dApps while in a seamless development environment similar to that of Web 2.0 development. He did this by  harnessing the power of innovative technologies like Wasm, the Actor Model, and Persistent Memory. These technologies significantly enhance smart contract development and provide a seamless end-user experience and provide the foundation for the development of Vara Network.  1. Q2 2021 - Pre-Seed Round: In the second quarter of 2021, the Protocol secured its initial funding through a pre-seed round. This likely involved seeking investment from early-stage investors or venture capitalists to kickstart the development of the project.  2. Q4 2021 - Seed Round: In December 2021 raised $12 Million in Venture Round. Private investment round led by Blockchange Venture. In addition to Blockchange, other top venture capital funds participated in this round, including Three  Arrows Capital, Lemniscap, Distributed Global, LAO, Mechanism Capital, Bitscale, Spartan Group LLC, HashKey, DI Ventures, Elysium Venture Capital, Signum Capital and P2P Economy lead by Konstantin Lomashuk, along with a number of top executives of Web3 Foundation and Parity Technologies. Dr. Gavin Wood, Founder and ex-CEO of Parity Technologies and one of the key individual investors participating in this round.  3. 2022 - Intensive Scaling and Development, First Test Integrations: Throughout the year 2022, Vara was focused on two primary activities. First, the engagement in an extensive outreach process to build up the team. Second, the project advanced its technical development efforts and started working on integrating their technology with various test environments to ensure its functionality and viability.  4. Q4 2022 - Testnet Launch.   5. Q1 2023 - PoA Launch: In the first quarter of 2023, Vara achieved launch of its Proof of Authority (PoA) consensus network, which is a chain candidate for mainnet.  Current Status of Vara:  Presently, the project boasts a talented and diverse decentralized workforce, consisting of dozens of engineers and other community members  to drive the project's success.  One of the remarkable aspects of Vara is its substantial pipeline of initiatives with over 40 projects.  What’s next for your project? Current projects being researched and developed by the community:  - Intensive testing and improvement of the actor model features in the blockchain space  - Launch of the key stack of dApps in our parallel and asynchronous environment   - Development of innovative infrastructure solutions (e.g offchain zk actors including machine learning) independently and together with the segment leaders  What can your token be used for? VARA tokens maintain core utility features required for the network to operate: transaction fees staking and network security governance other: gas pools for gas reservation  Contributors to the Gear protocol are exploring the mechanics of how to distribute a portion of block rewards directly toward dApp developers

Vara Network

Vara Network is actively trending amid widespread community excitement, primarily driven by persistent buzz around potential new major exchange listings and a noticeable surge in trading volume. The community emphasizes its core utility as a Layer 1 network, featuring an AI-integrated exchange and cross-chain bridging technology, with many anticipating substantial "altseason" gains. Discussions frequently highlight its perceived undervaluation and the significant slowing of token dilution as key catalysts for future appreciation within the evolving crypto landscape.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending as a federal appeals court denied an emergency request to halt its pipeline restart, a development bulls view as clearing a major regulatory hurdle and potentially igniting a short squeeze. Conversely, community sentiment remains split, with bears highlighting ongoing legal challenges from the California Attorney General and environmental groups, alongside financial concerns, contributing to significant volatility in this high-risk energy play.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

CRO is actively trending following major strategic partnerships, including Trump Media's plans for digital token distribution on the Cronos chain and Crypto.com's collaboration with High Roller Technologies to enter the prediction markets. The community is highly engaged, anticipating significant growth from these catalysts and proposed CRO investment products, with renewed interest also fueled by ecosystem meme coins like $CAW despite some frustration over price action.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is actively discussed as investors grapple with its stagnant valuation despite consistent operational growth and aggressive store expansion across markets like New York and Singapore. The community remains sharply divided between those who champion its superior product and market penetration against rivals like Starbucks, and those who express frustration over perceived stock manipulation and the ongoing delay in uplisting from OTC. This divergence reflects a core debate on the company's future trajectory and shareholder value realization.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is experiencing strong upward momentum following the FDA approval of its game-changing twice-yearly HIV prevention drug, Yeztugo, alongside robust Q2 earnings that exceeded expectations and a raised full-year outlook. The community is actively discussing how this solidifies Gilead's leading HIV franchise while highlighting its aggressive expansion into oncology through recent strategic acquisitions and partnerships. This diversification and renewed pipeline strength are fueling investor optimism, with the stock recently breaking out to new highs within the competitive biotech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC...

Short Interest in ADC Therapeutics SA (NYSE:ADCT) Drops By 47.2%

ADC Therapeutics SA (NYSE:ADCT - Get Free Report) saw a large decline in short interest in the month of December. As of December 31st, there was short interest totaling 3,573,570 shares, a decline of...

Are Medical Stocks Lagging  ADC Therapeutics (ADCT) This Year?

Here is how ADC Therapeutics SA (ADCT) and Agenus (AGEN) have performed compared to their sector so far this year.

ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages

ADC Therapeutics SA (NYSE:ADCT - Get Free Report) has earned an average rating of "Moderate Buy" from the six brokerages that are currently covering the company, Marketbeat.com reports. One...

ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates

ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025...

ADC Therapeutics Announces New Employee Inducement Grant

ADC Therapeutics Announces New Employee Inducement Grant ADC Therapeutics Announces New Employee Inducement Grant PR Newswire LAUSANNE, Switzerland, Jan. 2, 2026 LAUSANNE, Switzerland, Jan. 2, 2026...

ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why

ADC Therapeutics (ADCT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.

Adc Therapeutics SA

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

ADCT
Adc Therapeutics SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADCT News

ADCTAdc Therapeutics SA